The elevated release of these IFN-related factors in the HPAFII-CAR T cell co-culture suggested a potential correlation between higher tumor-associated IFN activation and stronger PDA resistance to CAR T cell killing. The gene discussed is IFNA1; the disease is Patent ductus arteriosus.